(MREO) Mereo BioPharma - Performance -21.9% in 12m
Compare MREO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
12.28%
#26 in Group
Rel. Strength
30.49%
#5531 in Universe
Total Return 12m
-21.94%
#61 in Group
Total Return 5y
93.60%
#21 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -9.55%
37th Percentile in Group
12m Total Return: MREO (-21.9%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: MREO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MREO
| Total Return (including Dividends) | MREO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 37.50% | 11.81% | 13.81% |
| 3 Months | -19.87% | -13.61% | -6.30% |
| 12 Months | -21.94% | -12.29% | 10.65% |
| 5 Years | 93.60% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | MREO | XBI | S&P 500 |
| 1 Month | 68.7% | 72.9% | 83% |
| 3 Months | -47.2% | -83% | -75.3% |
| 12 Months | -61.4% | -51.6% | 50.1% |
| 5 Years | 13.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #69 | 23.0% | 20.8% |
| 3 Month | #80 | -7.24% | -14.5% |
| 12 Month | #62 | -11.0% | -29.5% |
| 5 Years | #19 | 158% | -6.82% |
FAQs
Does MREO Mereo BioPharma outperforms the market?
No,
over the last 12 months MREO made -21.94%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months MREO made -19.87%, while XBI made -13.61%.
Over the last 3 months MREO made -19.87%, while XBI made -13.61%.
Performance Comparison MREO vs Indeces and Sectors
MREO vs. Indices MREO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.10% | 23.7% | -38.3% | -32.6% |
| US NASDAQ 100 | QQQ | -8.29% | 20.1% | -38.5% | -33.6% |
| US Dow Jones Industrial 30 | DIA | -8.51% | 27.5% | -38.0% | -29.7% |
| German DAX 40 | DAX | -8.08% | 22.5% | -64.5% | -47.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.3% | 25.7% | -39.0% | -29.3% |
| Hongkong Hang Seng | HSI | -11.3% | 17.6% | -46.6% | -35.6% |
| India NIFTY 50 | INDA | -3.18% | 32.7% | -38.7% | -21.7% |
| Brasil Bovespa | EWZ | -9.15% | 20.3% | -47.0% | -13.6% |
MREO vs. Sectors MREO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.74% | 24.1% | -45.3% | -43.5% |
| Consumer Discretionary | XLY | -8.48% | 23.3% | -37.3% | -36.2% |
| Consumer Staples | XLP | -7.24% | 30.9% | -45.2% | -31.1% |
| Energy | XLE | -7.92% | 30.7% | -31.7% | -12.5% |
| Financial | XLF | -9.20% | 24.0% | -45.4% | -44.4% |
| Health Care | XLV | -5.09% | 36.6% | -33.3% | -17.9% |
| Industrial | XLI | -9.79% | 20.7% | -39.7% | -32.9% |
| Materials | XLB | -7.90% | 23.9% | -33.4% | -16.7% |
| Real Estate | XLRE | -6.78% | 26.0% | -39.0% | -37.4% |
| Technology | XLK | -9.18% | 16.3% | -35.4% | -29.0% |
| Utilities | XLU | -8.15% | 27.9% | -45.9% | -39.4% |
| Aerospace & Defense | XAR | -10.1% | 16.3% | -49.8% | -49.3% |
| Biotech | XBI | -1.51% | 25.7% | -18.1% | -9.65% |
| Homebuilder | XHB | -8.57% | 26.0% | -25.1% | -14.4% |
| Retail | XRT | -10.0% | 22.9% | -34.0% | -20.5% |